The root of chronic pain often lies in a flawed mental model of how the body is constructed and moves. Changing your conceptual framework—for instance, from a rigid skeletal model to a fluid, pressure-based one—can be more powerful for healing than any specific physical intervention.

Unlike acute pain which signals immediate tissue damage, chronic pain often persists after the body has physically healed. Conditions like fibromyalgia represent a disease of the pain system itself, where nerves have fundamentally changed their function and continue to send alarm signals without an ongoing injury.

AAVantgarde learned from its Usher syndrome trial that capturing patient-reported outcomes is essential, especially when traditional functional endpoints like eye charts are slow to change. This strategy ensures they capture meaningful data on patient quality of life, which can be crucial for demonstrating therapeutic benefit in slowly progressing diseases.

A patient's reminder that even clinically-graded "mild" side effects like grade 2 diarrhea can be debilitating highlights a disconnect between clinical assessment and patient experience. This underscores the need for oncologists to consider the real-world impact of toxicities, like the ability to leave the house, when choosing a treatment regimen.

A patient on an experimental pancreatic cancer drug emphasized that its greatest benefit was giving her 10 months of a normal life back—working and being a mother and wife. This highlights how quality of life can be as crucial to patients as traditional efficacy endpoints.

In desmoid tumors, traditional RECIST criteria for tumor response are inadequate. Patients report significant improvements in pain and functional status even with minor tumor shrinkage that doesn't qualify as a partial response, making patient-reported outcomes a more meaningful endpoint.

Effective chronic pain treatment requires more than a single intervention. The gold standard is a multidisciplinary team—including physicians, pharmacists, physical therapists, and psychologists—working together. However, access to this expensive and resource-intensive model of care remains a major challenge for patients.

While outsiders assume walking is the ultimate recovery goal, NervGen's research reveals that regaining hand function for daily tasks like eating or using a computer is the most vital improvement for patient independence. This highlights the importance of patient-defined quality-of-life endpoints in clinical trials.

The brain and body naturally produce powerful pain-lowering chemicals, including serotonin, dopamine, and endorphins (the body's own opioids). These can be actively released through specific behaviors like movement, exercise, laughter, and social connection, giving individuals a way to directly manage their pain levels without external medication.